Renal dysfunction in heart failure patients: what is the evidence? (Q36773681)

16 August 2017

1 reference

title

Renal dysfunction in heart failure patients: what is the evidence? (English)

1 reference

16 August 2017

Heath E Saltzman

1

1 reference

16 August 2017

Kumar Sharma

2

1 reference

16 August 2017

Paul J Mather

3

1 reference

16 August 2017

Sharon Rubin

4

1 reference

16 August 2017

Suzanne Adams

5

1 reference

16 August 2017

David Joshua Whellan

6

1 reference

16 August 2017

29 March 2007

1 reference

16 August 2017

Heart Failure Reviews

1 reference

16 August 2017

12

1 reference

16 August 2017

1

1 reference

16 August 2017

37-47

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-007-9006-5

16 August 2017

0 references

cites work

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9006-5

Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9006-5

Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9006-5

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9006-5

Why do patients with congestive heart failure tolerate the initiation of beta-blocker therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9006-5

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-007-9006-5

Renal insufficiency predicts the time to first appropriate defibrillator shock.

21 January 2018

1 reference

12 December 2020

Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.

1 reference

12 December 2020

Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables

1 reference

12 December 2020

The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency

1 reference

12 December 2020

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

12 December 2020

Optimizing ACE-inhibitor therapy for chronic kidney disease

1 reference

12 December 2020

Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community

1 reference

12 December 2020

Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function

1 reference

12 December 2020

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

12 December 2020

Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol

1 reference

12 December 2020

Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals

1 reference

12 December 2020

Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival

1 reference

12 December 2020

Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] Trial)

1 reference

12 December 2020

Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial

1 reference

12 December 2020

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

1 reference

12 December 2020

Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction.

1 reference

12 December 2020

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

1 reference

12 December 2020

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

12 December 2020

The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure

1 reference

12 December 2020

Mild renal insufficiency and risk of congestive heart failure in men and women > or =70 years of age.

1 reference

12 December 2020

Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.

1 reference

12 December 2020

Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study

1 reference

12 December 2020

Predictors of worsening renal function in adult patients with congestive heart failure receiving recombinant human B-type brain natriuretic peptide (nesiritide).

1 reference

12 December 2020

Renal insufficiency as an independent predictor of mortality among women with heart failure

1 reference

12 December 2020

Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction

1 reference

12 December 2020

Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials

1 reference

12 December 2020

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

12 December 2020

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

1 reference

12 December 2020

Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention

1 reference

12 December 2020

Rationale, design, and organization of the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF). The International Steering Committee

1 reference

12 December 2020

Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial

1 reference

12 December 2020

Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investiga

1 reference

12 December 2020

Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group

1 reference

12 December 2020

Lifetime Risk for Developing Congestive Heart Failure

1 reference

12 December 2020

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

1 reference

12 December 2020

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

1 reference

12 December 2020

Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study

1 reference

12 December 2020

Preventing microalbuminuria in type 2 diabetes

1 reference

12 December 2020

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

12 December 2020

Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction

1 reference

12 December 2020

Efficacy and safety of benazepril for advanced chronic renal insufficiency

1 reference

12 December 2020

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

1 reference

12 December 2020

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

12 December 2020

Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients

1 reference

12 December 2020

Therapy insight: how changes in renal function with increasing age affect cardiovascular drug prescribing

1 reference

12 December 2020

Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial). CONSENSUS Trial Study Group

1 reference

12 December 2020

Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.

1 reference

12 December 2020

The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function

1 reference

12 December 2020

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

12 December 2020

Prediction of creatinine clearance from serum creatinine

1 reference

12 December 2020

Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade

1 reference

12 December 2020

Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial

1 reference

12 December 2020

Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?

1 reference

12 December 2020

Anemia and chronic kidney disease are associated with poor outcomes in heart failure patients

1 reference

12 December 2020

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

12 December 2020

Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure

1 reference

12 December 2020

Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure

1 reference

12 December 2020

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

12 December 2020

The prognostic importance of different definitions of worsening renal function in congestive heart failure

1 reference

12 December 2020

Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study

1 reference

12 December 2020

Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure.

1 reference

12 December 2020

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

12 December 2020

Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system

1 reference

12 December 2020

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

1 reference

12 December 2020

The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease

1 reference

12 December 2020

Effect of carvedilol on survival in severe chronic heart failure

1 reference

12 December 2020

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

12 December 2020

Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure

1 reference

12 December 2020

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

1 reference

12 December 2020

Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine

1 reference

12 December 2020

Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure

1 reference

12 December 2020

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise th

1 reference

12 December 2020

Relationship between heart failure treatment and development of worsening renal function among hospitalized patients

1 reference

12 December 2020

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic

1 reference

12 December 2020

10.1007/S10741-007-9006-5

Identifiers

DOI

1 reference

16 August 2017

1 reference